FGF-23 and Mortality in Dialysis patients- Journal Club
Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting.
Presenter Disclosure Information Robert E. Michler, M.D. Influence of Left Ventricular Volume Reduction on Outcome After Coronary Artery Bypass Grafting.
I International Symposium on Prevention of Cardiovascular Diseases Kraków 9-11.06.2005 Prevention of Heart Failure after AMI MAŁOPOLSKA STUDY A 2256-Patients.
Hodgkin’s Disease an Update. Is more always better? Jeffrey Schriber, M.D. Medical Director Cancer Transplant Institute Virginia G. Piper Cancer Center.
Survival analysis
PRAMI clinical trial (for STEMI intervention)
Normal Saline is not Normal? ; Chloride liberal vs. Chloride restrictive IV Fluid
Sepsisandseveresepsis
Beta blockers in SIHD: Yes, all patients should receive them !
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation.
FORECASTING ONE-YEAR RENAL ALLOGRAFT FUNCTION AND SURVIVAL Yuriy Yushkov 1, Nikolina Icitovic 1, Ruslan Fedkiv 1, and Michael J. Goldstein 1,2 (1)New York.
